• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人谷胱甘肽转移酶在一氧化氮前体药物 JS-K 的生物转化中的作用。

Role of human glutathione transferases in biotransformation of the nitric oxide prodrug JS-K.

机构信息

Department of Biochemistry and Biophysics, Arrhenius Laboratories, Stockholm University, SE-10691, Stockholm, Sweden.

出版信息

Sci Rep. 2021 Oct 21;11(1):20765. doi: 10.1038/s41598-021-00327-1.

DOI:10.1038/s41598-021-00327-1
PMID:34675290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8531399/
Abstract

Nitric oxide (NO) plays a prominent physiological role as a low-molecular-mass signal molecule involved in diverse biological functions. Great attention has been directed to pharmacologically modulating the release of NO for various therapeutic applications. We have focused on O-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate (JS-K) as an example of diazeniumdiolate prodrugs with potential for cancer chemotherapy. JS-K is reportedly activated by glutathione conjugation by glutathione transferase (GST), but the scope of activities among the numerous members of the GSTome is unknown. We demonstrate that all human GSTs tested except GST T1-1 are active with JS-K as a substrate, but their specific activities are notably spanning a > 100-fold range. The most effective enzyme was the mu class member GST M2-2 with a specific activity of 273 ± 5 µmol min mg and the kinetic parameters Km 63 µM, k 353 s, k/Km 6 × 10 M s. The abundance of the GSTs as an ensemble and their high catalytic efficiency indicate that release of NO occurs rapidly in normal tissues such that this influence must be considered in clarification of the tumor-killing effect of JS-K.

摘要

一氧化氮(NO)作为一种参与多种生物功能的低分子量信号分子,在生理学中起着重要作用。人们非常关注通过药理学调节 NO 的释放,以用于各种治疗应用。我们以 O-(2,4-二硝基苯基)-1-[(4-乙氧羰基)哌嗪-1-基]二氮烯-1,2-二醇盐(JS-K)为例,研究了具有癌症化疗潜力的二氮烯二醇前药。据报道,JS-K 通过谷胱甘肽转移酶(GST)的谷胱甘肽缀合而被激活,但 GSTome 中众多成员的活性范围尚不清楚。我们证明,除 GST T1-1 外,所有测试的人 GST 均能以 JS-K 作为底物发挥作用,但它们的比活性显著跨越了 100 倍的范围。最有效的酶是μ类成员 GST M2-2,其比活性为 273±5 μmol min mg,动力学参数 Km 为 63 μM,k 为 353 s,k/Km 为 6×10 M s。GST 作为一个整体的丰度及其高催化效率表明,NO 的释放会在正常组织中迅速发生,因此在阐明 JS-K 的肿瘤杀伤作用时必须考虑到这一影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/8531399/60fbb0c31f8c/41598_2021_327_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/8531399/e431de94c692/41598_2021_327_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/8531399/44dddcbacf14/41598_2021_327_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/8531399/39933e7c798a/41598_2021_327_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/8531399/60fbb0c31f8c/41598_2021_327_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/8531399/e431de94c692/41598_2021_327_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/8531399/44dddcbacf14/41598_2021_327_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/8531399/39933e7c798a/41598_2021_327_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3b/8531399/60fbb0c31f8c/41598_2021_327_Fig4_HTML.jpg

相似文献

1
Role of human glutathione transferases in biotransformation of the nitric oxide prodrug JS-K.人谷胱甘肽转移酶在一氧化氮前体药物 JS-K 的生物转化中的作用。
Sci Rep. 2021 Oct 21;11(1):20765. doi: 10.1038/s41598-021-00327-1.
2
Cellular distribution studies of the nitric oxide-generating antineoplastic prodrug O(2) -(2,4-dinitrophenyl)1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate formulated in Pluronic P123 micelles.O(2)-(2,4-二硝基苯基)1-((4-乙氧羰基)哌嗪-1-基)二氮烯-1,2-二醇ate 在 Pluronic P123 胶束中制成的抗肿瘤前药的细胞分布研究。
J Pharm Pharmacol. 2013 Sep;65(9):1329-36. doi: 10.1111/jphp.12100. Epub 2013 Jul 10.
3
JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity.JS-K,一种二氮烯二醇盐类的谷胱甘肽/谷胱甘肽S-转移酶激活的一氧化氮供体,具有强大的抗肿瘤活性。
Mol Cancer Ther. 2003 Apr;2(4):409-17.
4
Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs.谷胱甘肽/谷胱甘肽S-转移酶激活的一氧化氮前药的合成、机理研究及抗增殖活性
Bioorg Med Chem. 2008 Nov 15;16(22):9764-71. doi: 10.1016/j.bmc.2008.09.063. Epub 2008 Sep 30.
5
Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balance.释放一氧化氮的前药通过破坏细胞氧化还原平衡引发癌细胞死亡。
Redox Biol. 2013 Feb 1;1(1):115-24. doi: 10.1016/j.redox.2012.12.002. eCollection 2013.
6
The nitric oxide prodrug JS-K and its structural analogues as cancer therapeutic agents.一氧化氮前药JS-K及其结构类似物作为癌症治疗药物
Anticancer Agents Med Chem. 2009 Sep;9(7):798-803. doi: 10.2174/187152009789056949. Epub 2009 Sep 1.
7
Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation.一氧化氮前药与金属化学疗法:JS-K和CB-3-100通过增加细胞摄取来增强砷和顺铂的细胞致死性。
Mol Cancer Ther. 2004 Jun;3(6):709-14.
8
JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomas.JS-K,一种谷胱甘肽 S-转移酶激活的一氧化氮供体,具有恶性神经胶质瘤的抗肿瘤活性。
Neurosurgery. 2012 Feb;70(2):497-510; discussion 510. doi: 10.1227/NEU.0b013e31823209cf.
9
Nitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53.一氧化氮前药JS-K抑制泛素E1并杀死保留野生型p53的肿瘤细胞。
Oncogene. 2009 Jan 29;28(4):619-24. doi: 10.1038/onc.2008.401. Epub 2008 Nov 3.
10
Nitroreductase-activated nitric oxide (NO) prodrugs.硝基还原酶激活的一氧化氮(NO)前药。
Bioorg Med Chem Lett. 2013 Nov 1;23(21):5964-7. doi: 10.1016/j.bmcl.2013.08.066. Epub 2013 Aug 22.

引用本文的文献

1
Click chemistry and drug delivery: A bird's-eye view.点击化学与药物递送:鸟瞰
Acta Pharm Sin B. 2023 May;13(5):1990-2016. doi: 10.1016/j.apsb.2022.10.015. Epub 2022 Oct 22.
2
Glutathione--Transferases as Potential Targets for Modulation of Nitric Oxide-Mediated Vasodilation.谷胱甘肽转移酶作为调节一氧化氮介导的血管舒张的潜在靶点。
Biomolecules. 2022 Sep 13;12(9):1292. doi: 10.3390/biom12091292.

本文引用的文献

1
A review of the relatively complex mechanism of JS-K induced apoptosis in cancer cells.对JS-K诱导癌细胞凋亡的相对复杂机制的综述。
Transl Cancer Res. 2019 Aug;8(4):1602-1608. doi: 10.21037/tcr.2019.07.20.
2
Sphingosine 1-Phosphate Liposomes for Targeted Nitric Oxide Delivery to Mediate Anticancer Effects against Brain Glioma Tumors.鞘氨醇 1-磷酸脂质体靶向递送至介导脑胶质瘤肿瘤的抗癌作用。
Adv Mater. 2021 Jul;33(30):e2101701. doi: 10.1002/adma.202101701. Epub 2021 Jun 9.
3
Nitric Oxide Prodrug Delivery and Release Monitoring Based on a Galactose-Modified Multifunctional Nanoprobe.
基于半乳糖修饰的多功能纳米探针的一氧化氮前药传递和释放监测。
Anal Chem. 2021 Jun 1;93(21):7625-7634. doi: 10.1021/acs.analchem.1c00287. Epub 2021 May 19.
4
Human variability in glutathione-S-transferase activities, tissue distribution and major polymorphic variants: Meta-analysis and implication for chemical risk assessment.人类谷胱甘肽-S-转移酶活性、组织分布和主要多态变体的个体差异:荟萃分析及其对化学风险评估的影响。
Toxicol Lett. 2021 Feb 1;337:78-90. doi: 10.1016/j.toxlet.2020.11.007. Epub 2020 Nov 12.
5
The evolving landscape for cellular nitric oxide and hydrogen sulfide delivery systems: A new era of customized medications.细胞一氧化氮和硫化氢输送系统的不断发展:定制药物的新时代。
Biochem Pharmacol. 2020 Jun;176:113931. doi: 10.1016/j.bcp.2020.113931. Epub 2020 Mar 26.
6
Glutathione -transferase π: a potential role in antitumor therapy.谷胱甘肽-S-转移酶π:在抗肿瘤治疗中的潜在作用
Drug Des Devel Ther. 2018 Oct 23;12:3535-3547. doi: 10.2147/DDDT.S169833. eCollection 2018.
7
Nitric oxide for cancer therapy.用于癌症治疗的一氧化氮。
Future Sci OA. 2015 Aug 1;1(1):FSO44. doi: 10.4155/fso.15.44. eCollection 2015 Aug.
8
Identification of new inhibitors for human hematopoietic prostaglandin D2 synthase among FDA-approved drugs and other compounds.在 FDA 批准的药物和其他化合物中鉴定人源造血前列腺素 D2 合酶的新型抑制剂。
Chem Biol Interact. 2015 Mar 5;229:91-9. doi: 10.1016/j.cbi.2015.01.014. Epub 2015 Jan 17.
9
Glutathione Transferase (GST)-Activated Prodrugs.谷胱甘肽转移酶(GST)激活前药。
Pharmaceutics. 2013 Apr 2;5(2):220-31. doi: 10.3390/pharmaceutics5020220.
10
Cellular distribution studies of the nitric oxide-generating antineoplastic prodrug O(2) -(2,4-dinitrophenyl)1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate formulated in Pluronic P123 micelles.O(2)-(2,4-二硝基苯基)1-((4-乙氧羰基)哌嗪-1-基)二氮烯-1,2-二醇ate 在 Pluronic P123 胶束中制成的抗肿瘤前药的细胞分布研究。
J Pharm Pharmacol. 2013 Sep;65(9):1329-36. doi: 10.1111/jphp.12100. Epub 2013 Jul 10.